Comparing the Safety and Efficacy of Celecoxib for the Treatment of Osteoarthritis in Asian and non-Asian Populations: An Analysis of Data from Two Randomized, Double-blind, Placebo-controlled, Active-comparator Trials
Crossref DOI link: https://doi.org/10.1007/s40122-017-0081-6
Published Online: 2017-09-18
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lubis, Andri
Wang, Wei
Lima, Graça
Fayyad, Rana
Walker, Chris
Funding for this research was provided by:
Pfizer UK